Eve Health Group Limited has released a press release.
Reinstatement to Quotation
Filed with ASX ·
6ix hasn’t read this filing yet.
EVE Health Group Limited on 6ix
In the deck
Story so far
Earlier from EVE Health
- EVE to Acquire Nextract, Expanding into $5.3B ED Market
- Suspension from Quotation
- Quarterly Activities/Appendix 5B Cash Flow Report
- Preliminary Final Report
- Sale of Robyndale Property (Amended)
Later from EVE Health
- Notice of General Meeting/Proxy Form
- Results of Meeting
- EVE Completes Nextract Acquisition
- Prescribing Agreement for ED and Dysmenorrhea Products
- EVE Submits First Commercial Purchase Order for Dyspro
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health